Your Cholesterol Looks Fine, But Your Genes May Tell a Different Story.

Your APOE gene produces a protein that binds to LDL cholesterol particles and escorts them out of your bloodstream into your liver for disposal. This is a critical cleanup job. Without efficient APOE function, cholesterol accumulates in your blood and in your artery walls.

The problem: APOE comes in three variants, called e2, e3, and e4. The e4 variant, carried by roughly 25 percent of people with European ancestry, is significantly less efficient at clearing LDL. If you inherit one or two copies of the e4 allele, your liver clears LDL cholesterol roughly 30 to 40 percent more slowly than someone with the e3 variant. This means your blood cholesterol stays elevated even if you eat well, and your cardiovascular disease risk rises independently.

This shows up in your life as: persistently elevated LDL despite a good diet, a strong family history of early heart disease, aggressive atherosclerosis on imaging, and increased Alzheimer’s disease risk later in life. Your cardiologist might recommend a statin; if you carry e4, you likely need one.

MTHFR catalyzes a critical step in converting homocysteine into methionine. Homocysteine is a sticky, pro-inflammatory amino acid. If it builds up in your blood, it damages artery walls, increases clot formation, and accelerates atherosclerosis. Your body is designed to keep homocysteine low by converting it quickly. MTHFR is the enzyme that makes this conversion efficient.

The problem: The C677T variant in MTHFR, carried by roughly 40 percent of people with European ancestry, reduces enzyme activity by 30 to 70 percent depending on whether you carry one or two copies. This leaves homocysteine circulating in your blood longer, where it promotes inflammation and clot formation. Your cholesterol panel won’t show this. Standard blood tests often miss elevated homocysteine, or miss that it’s genetically driven and can be addressed.

This shows up as: moderately elevated homocysteine on blood testing, early atherosclerosis, stroke or heart attack risk that doesn’t match your cholesterol levels, or family history of clotting events. You might have done everything right and still find yourself at higher risk.

ACE is a critical enzyme in the renin-angiotensin system, the body’s main blood pressure control switch. It converts angiotensin I into angiotensin II, a hormone that makes blood vessels constrict and raises blood pressure. In healthy amounts, this is necessary. But when ACE is overactive, your blood vessels stay constricted, and your baseline blood pressure drifts higher.

The problem: The ACE gene has a common I/D polymorphism (insertion-deletion). The D allele, which approximately 25 percent of the population carries in the D/D homozygous state, is associated with higher ACE activity. People with D/D variants produce more angiotensin II, their blood vessels constrict more aggressively, and their baseline blood pressure runs higher even at rest. Additionally, these individuals show greater cardiac hypertrophy (thickening of the heart muscle), which itself becomes a risk factor for arrhythmias and heart failure.

This shows up as: high blood pressure that’s harder to control with a single medication, white-coat hypertension or masked hypertension, left ventricular hypertrophy on an echocardiogram, or a strong family history of early hypertension. You might need ACE inhibitors or ARBs specifically, not just any blood pressure drug.

Nitric oxide is a signaling molecule produced by the cells lining your blood vessels. It tells smooth muscle cells to relax, which dilates the vessels and allows blood to flow freely. Healthy arteries are constantly making and releasing nitric oxide. Damaged arteries lose this ability. NOS3 is the enzyme that produces nitric oxide; it’s essential for keeping your blood vessels young and flexible.

The problem: The Glu298Asp variant in NOS3, carried by 30 to 40 percent of the population, impairs the enzyme’s function. People with this variant produce less nitric oxide, especially under stress or with exercise. This means your blood vessels don’t dilate as much when your body demands more blood flow, and they stay stiffer during everyday activities. The result is higher baseline blood pressure, reduced exercise tolerance, and accelerated atherosclerosis.

This shows up as: high blood pressure that feels resistant to exercise, poor exercise tolerance despite good conditioning, cold extremities, erectile dysfunction (a sensitive marker of endothelial dysfunction), or early atherosclerosis on imaging. You might feel like exercise should help your blood pressure, but the genetic constraint is limiting your vessel flexibility.

Factor V is a critical component of your blood clotting cascade. When you bleed, clotting factors activate in sequence to form a plug and stop the bleeding. Factor V is one of the key players. Normally, your body also has natural brakes on clotting to prevent unwanted clots. Protein C is one of these brakes; it inactivates Factor V after the clot has done its job. Without this system, clots would form everywhere.

The problem: The Factor V Leiden variant (R506Q), carried by roughly 5 percent of people with European ancestry, creates a version of Factor V that resists inactivation by protein C. This means clots form more easily and persist longer, multiplying your venous thrombosis risk by 4 to 8 times. If you’re also taking oral contraceptives, the risk jumps to 80 times. Arterial clots (strokes, heart attacks) are less directly affected, but the prothrombotic state increases overall cardiovascular risk.

This shows up as: unexplained leg swelling or pain, a personal history of deep vein thrombosis or pulmonary embolism, recurrent miscarriage (clots in placental vessels), or family history of thrombotic events. You might be told not to take oral contraceptives, or warned before surgery. This is a gene where knowing your status changes your medical management directly.

Lipoprotein(a), or Lp(a), is a particle in your blood that looks similar to LDL cholesterol but carries extra baggage: it includes a copy of apolipoprotein(a), a sticky protein that promotes inflammation and clotting. Unlike LDL cholesterol, which responds to diet and statins, Lp(a) levels are almost entirely genetically determined. You can eat perfectly and still have high Lp(a). You can be lean and active and still have high Lp(a). Your genetics control whether your body makes a lot of this pro-clotting, pro-inflammatory particle or very little.

The problem: Roughly 20 percent of the population carries genetic variants that lead to high Lp(a) levels. High Lp(a) is an independent cardiovascular risk factor as powerful as elevated LDL cholesterol, increasing your risk of heart attack and stroke by 2 to 4 times, depending on your level. The worst part: standard cholesterol testing doesn’t measure Lp(a), so most people with this genetic risk never know they have it.

This shows up as: early heart disease in the family despite normal cholesterol, high Lp(a) on blood testing (>50 mg/dL is considered elevated), unexpected atherosclerosis on imaging, or a family history of heart attacks in slim, active people. Your cardiologist might miss this entirely if they don’t specifically test Lp(a).